End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,490 KRW | -0.36% | +0.37% | -12.02% |
Business Summary
Number of employees: 160
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
API and Synthesis
97.6
%
| - | - | 119,121 | 97.6 % | - |
Material
2.4
%
| - | - | 2,877 | 2.4 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 103,711 | 100.0 % | 121,998 | 100.0 % | +17.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Ho Hong
CEO | Chief Executive Officer | 53 | - |
Dong-Woon Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Jong-Hak Lee
BRD | Director/Board Member | 53 | - |
Hyeon-Su Ahn
SAM | Sales & Marketing | 52 | - |
Kyung-Ho Park
AUD | Comptroller/Controller/Auditor | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seon-Gyu Choi
BRD | Director/Board Member | 70 | - |
Jong-Ho Hong
CEO | Chief Executive Officer | 53 | - |
Jong-Hak Lee
BRD | Director/Board Member | 53 | - |
Hak-Seon Kim
BRD | Director/Board Member | 53 | - |
Yoon-Cheol Kim
BRD | Director/Board Member | 66 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,069,269 | 18,650,413 ( 38.01 %) | 117 ( 0.000238 %) | 38.01 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
117 | 0.00% | 531 $ |
Company contact information
Kukjeon Pharmaceutical Co., Ltd.
282 Hagui-ro Dongan-gu
14056, Anyang-si
+
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-12.02% | 196M | |
+20.91% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+11.99% | 13.64B | |
+39.15% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A307750 Stock
- Company KUKJEON PHARMACEUTICAL Co., Ltd